Tag Archives: Department of Health
Naughty Localities Need to Obey NICE, or Else!
Like governors in the US vowing to block Medicaid expansion in their home states, local primary care trusts (PCTs) in the UK don’t always follow national guidelines on drug access due to budgetary concerns. But that may change in 2013; according to comments made by Minister David Willetts last month, NHS could face monetary penalties [...]
Posted in Agency Insight, Global, Legal, Market Access, Regulatory, Strategy, healthcare, pricing Also tagged England, Minister David Willetts, NHS, PCTs, Primary Care Trusts, public policy, Sir Michael Rawlins, UK Leave a comment
Pfizer Settles Whistleblower Case for $2.3 Billion
Image by Getty Images via Daylife
Pfizer, on Wednesday, agreed to pay $2.3 billion to end a US Department of Justice investigation citing the company for illegal off-label marketing tactics related to a number of products. It represents the largest single settlement of its type for a pharmaceutical company, topping Lilly’s $1.4 billion Zyprexa settlement reached [...]

UK Value-Based Pricing: Will Scotland Take a Different Approach?